The growth of the Asia Pacific NGS market is primarily due to the rising funding for Translational research bolstered by the region’s diverse population with unique genetic backgrounds and healthcare challenges. The global next-generation sequencing market, valued at US$12.13 billion in 2023, is forecasted to grow at a robust CAGR of 13.2%, reaching US$12.65 billion […]
